https://www.selleckchem.com/products/AZD0530.html
To our knowledge, we report the first case of corneal perforation in which evisceration was required following treatment with topical lifitegrast for chronic GVH. In the case presented here, it can be assumed that the underlying mechanisms leading to corneal perforation are multifactorial. Using drug accountability criteria, lifitegrast appears to be strongly associated with the development of bacterial keratitis and corneal perforation. To potentially limit peri-implant fractures our institution commonly implements a "stress-taper" fix
Like
Comment
Share
